Dikla Ben‐Shushan
- Pharmacology top 10%
- Cannabis and Cannabinoid Research 2
- Biomaterials top 10%
-
- MicroRNA in disease regulation 2
-
- Nanoplatforms for cancer theranostics 4
-
- RNA Interference and Gene Delivery 3
- Extracellular vesicles in disease 2
- Advanced biosensing and bioanalysis techniques 2
- Melanoma and MAPK Pathways 2
-
- Cancer Research and Treatments 2
Dikla Ben‐Shushan
21 papers receiving 866 citations
Peers
Comparison fields: 5 of 93
- Pharmacology 133
- Biomaterials 100
- Cancer Research 107
- Oncology 194
- Genetics 73
Countries citing papers authored by Dikla Ben‐Shushan
This map shows the geographic impact of Dikla Ben‐Shushan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dikla Ben‐Shushan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dikla Ben‐Shushan more than expected).
Fields of papers citing papers by Dikla Ben‐Shushan
This network shows the impact of papers produced by Dikla Ben‐Shushan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dikla Ben‐Shushan. The network helps show where Dikla Ben‐Shushan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dikla Ben‐Shushan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2021 | 56 | |
| 3 | 2021 | 129 | |
| 4 | 2020 | 5 | |
| 5 | 2020 | 13 | |
| 6 | 2017 | 79 | |
| 7 | 2017 | 20 | |
| 8 | 2017 | 79 | |
| 9 | 2017 | 17 | |
| 10 | 2016 | 68 | |
| 11 | 2016 | 1 | |
| 12 | 2015 | 62 | |
| 13 | 2013 | 53 | |
| 14 | 2012 | 14 | |
| 15 | 2009 | 11 | |
| 16 | 2008 | 7 | |
| 17 | 2005 | 39 | |
| 18 | 2005 | 81 | |
| 19 | 2004 | 37 | |
| 20 | 2003 | 97 |
About Dikla Ben‐Shushan
Dikla Ben‐Shushan is a scholar working on Immunology and Allergy, Biotechnology and Cancer Research, having authored 21 papers that have together received 874 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), RNA Interference and Gene Delivery (3 papers), Extracellular vesicles in disease (2 papers), Cancer Research and Treatments (2 papers), Cannabis and Cannabinoid Research (2 papers), MicroRNA in disease regulation (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Pharmacology (133 citations), Biomaterials (100 citations) and Cancer Research (107 citations). Dikla Ben‐Shushan has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Ronit Satchi‐Fainaro, Galia Tiram, Anat Eldar‐Boock, Eilam Yeini, Yosefa Avraham, Elliot M. Berry, Anna Scomparin, Shiran Ferber, Zvi Ram and Rachel Grossman. Their work appears in journals such as Nature Communications, Journal of Controlled Release, Cancer Research, Molecular Cancer Therapeutics and Pathobiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.